- Home
- RAPT vs ONDS Comparison
RAPT vs ONDS Comparison
Compare RAPT & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAPT | ONDS |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.4M | 2.8B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | RAPT | ONDS |
|---|---|---|
| Price | $31.66 | $10.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $57.00 | $10.00 |
| AVG Volume (30 Days) | 411.1K | ★ 80.0M |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $24,748,922.00 |
| Revenue This Year | N/A | $417.68 |
| Revenue Next Year | N/A | $244.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 208.40 |
| 52 Week Low | $5.67 | $0.57 |
| 52 Week High | $42.39 | $11.70 |
Technical Indicators
Market Signals| Indicator | RAPT | ONDS |
|---|---|---|
| Relative Strength Index (RSI) | 45.03 | 66.38 |
| Support Level | $33.01 | $8.21 |
| Resistance Level | $36.25 | $9.84 |
| Average True Range (ATR) | 2.52 | 0.92 |
| MACD | -0.48 | 0.15 |
| Stochastic Oscillator | 4.41 | 98.78 |
Price Performance
Historical ComparisonAbout RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.